Tumor PD-L1 status and CD8+ tumor-infiltrating T cells: markers of improved prognosis in oropharyngeal cancer-Reference-Cited by-同舟云学术

Tumor PD-L1 status and CD8+ tumor-infiltrating T cells: markers of improved prognosis in oropharyngeal cancer

Published:2017-07-06 Issue:46 Volume:8 Page:80443-80452
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

De Meulenaere Astrid¹,Vermassen Tijl¹,Aspeslagh Sandrine²,Deron Philippe³,Duprez Fréderic⁴,Laukens Debby⁵,Van Dorpe Jo⁶,Ferdinande Liesbeth⁶,Rottey Sylvie⁶¹

Affiliation:

1. Department of Medical Oncology, Ghent University Hospital, 9000 Ghent, Belgium

2. DITEP, Gustave Roussy Cancer Centre, 94800 Villejuif, France

3. Department of Head, Neck and Maxillo-Facial Surgery, Ghent University Hospital, 9000 Ghent, Belgium

4. Department of Radiation Oncology, Ghent University Hospital, 9000 Ghent, Belgium

5. Department of Internal Medicine, Ghent University Hospital, 9000 Ghent, Belgium

6. Department of Pathology, Ghent University Hospital, 9000 Ghent, Belgium

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor-stroma contact ratio - a novel predictive factor for tumor response to chemoradiotherapy in locally advanced oropharyngeal cancer;Translational Oncology;2024-08

2. Immunotherapy for Head and Neck Squamous Cell Carcinoma: Present and Future Approaches and Challenges;JCO Oncology Practice;2024-05-06

3. Expression of CD4+ and CD8+ Tumor-Infiltrating Lymphocytes in Oral Squamous Cell Carcinoma and Their Relationship With Clinicopathological Parameters: A Cross-Sectional Study;Cureus;2024-04-22

4. Prognostic role of PD-L1 Expression in Head and Neck Squamous Cell Carcinoma: An institutional experience from India;Pathology - Research and Practice;2024-01

5. Programmed Cell Death Ligand 1 Immunoexpression in Head and Neck Squamous Cell Carcinoma: A Narrative Review of Considerations for the Histopathologist;JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH;2024